90 related articles for article (PubMed ID: 30094307)
1. Acute localized exanthematous pustulosis (ALEP) caused by lamotrigine.
Hopkins Z; Frigerio A; Clarke JT
JAAD Case Rep; 2018 Aug; 4(7):645-647. PubMed ID: 30094307
[No Abstract] [Full Text] [Related]
2. Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS Syndromes - A Narrative Review.
Pakkir Maideen NM; Barakat IR; Jumale AH
Curr Drug Saf; 2024; 19(2):218-223. PubMed ID: 37151075
[TBL] [Abstract][Full Text] [Related]
3. Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.
Godfrey H; Jedlowski P; Thiede R
Australas J Dermatol; 2024 May; 65(3):243-253. PubMed ID: 38572842
[TBL] [Abstract][Full Text] [Related]
4. Ethical considerations in the management of drug severe cutaneous adverse reactions.
Buckey TM; Ferreira AL; Grant-Kels JM
J Am Acad Dermatol; 2024 Jan; ():. PubMed ID: 38224911
[No Abstract] [Full Text] [Related]
5. The Role of Frozen Section in the Rapid Diagnosis of Severe Cutaneous Adverse Drug Reactions.
Nicholas R; Bindra MS; Mathew L; Sathishkumar D; Lakshmanan J; George R
Indian Dermatol Online J; 2021; 12(1):78-83. PubMed ID: 33768026
[TBL] [Abstract][Full Text] [Related]
6. An observational study of severe cutaneous adverse reactions at a tertiary care teaching hospital.
Lekshmipriya K; Pradeesh A; Vasudevan B; Dash M; Sood A; Gera V
Med J Armed Forces India; 2023 Dec; 79(Suppl 1):S209-S216. PubMed ID: 38144617
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of cutaneous adverse drug reactions.
Mockenhaupt M
Allergol Select; 2017; 1(1):96-108. PubMed ID: 30402608
[TBL] [Abstract][Full Text] [Related]
8. Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System.
Godfrey H; Jedlowski P; Thiede R
J Cutan Med Surg; 2024; 28(1):51-58. PubMed ID: 38189282
[TBL] [Abstract][Full Text] [Related]
9. Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis.
Gallardo MA; Mallela T; Gilkey T; Himed S; Walker TD; Nusbaum KB; Korman A; Trinidad J; Chung C; Kaffenberger BH
J Am Acad Dermatol; 2023 May; 88(5):1142-1145. PubMed ID: 36442643
[No Abstract] [Full Text] [Related]
10. Severe adverse drug reactions.
Teo YX; Walsh SA
Clin Med (Lond); 2016 Feb; 16(1):79-83. PubMed ID: 26833523
[TBL] [Abstract][Full Text] [Related]
11. Severe cutaneous adverse drug reactions: incidence, clinical characteristics, treatment, and outcome in pediatric patients.
Na Bangxang P; Wisuthsarewong W; Nitiyarom R
Asian Pac J Allergy Immunol; 2024 Jan; ():. PubMed ID: 38183639
[TBL] [Abstract][Full Text] [Related]
12. Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.
Chen CB; Wu MY; Ng CY; Lu CW; Wu J; Kao PH; Yang CK; Peng MT; Huang CY; Chang WC; Hui RC; Yang CH; Yang SF; Chung WH; Su SC
Cancer Manag Res; 2018; 10():1259-1273. PubMed ID: 29844705
[TBL] [Abstract][Full Text] [Related]
13. A case of recalcitrant acute generalized exanthematous pustulosis with Sjogren's syndrome: Successfully treated with low-dose cyclosporine.
İslamoğlu ZGK; Karabağli P
Clin Case Rep; 2019 Sep; 7(9):1721-1724. PubMed ID: 31534735
[TBL] [Abstract][Full Text] [Related]
14. Drug Reaction with Eosinophilia and Systemic Symptoms Induced by Diosmin and Hesperidin: A Case Report.
Palakornkitti P; Rattananukrom T
Clin Cosmet Investig Dermatol; 2024; 17():1127-1132. PubMed ID: 38770090
[TBL] [Abstract][Full Text] [Related]
15. Lower extremity purpura as an uncommon presentation of acute generalized exanthematous pustulosis (AGEP).
Akpala CO; Sokumbi O; Comfere N; Takaichi M; Alavi A
Int J Dermatol; 2024 May; ():. PubMed ID: 38741275
[No Abstract] [Full Text] [Related]
16. Photoinduced acute exanthematous pustulosis caused by dicloxacillin and exposure to sunlight.
Nielsen RM; Pallesen KA
Clin Case Rep; 2020 Mar; 8(3):538-539. PubMed ID: 32185054
[TBL] [Abstract][Full Text] [Related]
17. Acute generalized exanthematous pustulosis in a postpartum woman.
Toyoshima H; Mizuno M; Tanigawa M; Tanaka H; Nakanishi Y; Sakabe S
Clin Case Rep; 2021 Jul; 9(7):e04462. PubMed ID: 34306687
[TBL] [Abstract][Full Text] [Related]
18. A rare case of acute generalized exanthematous pustulosis induced by gadobutrol.
Fetzer K; Forchhammer S; Silber T; Volc S
Contact Dermatitis; 2024 Apr; ():. PubMed ID: 38613226
[No Abstract] [Full Text] [Related]
19. Evolution of the spectrum of drugs associated with acute generalized exanthematous pustulosis over time: a pharmacovigilance study.
Matei I; Bettuzzi T; Peiffer B; Ingen-Housz-Oro S; Sbidian E; Lebrun-Vignes B
J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38762011
[No Abstract] [Full Text] [Related]
20. Multiple drug hypersensitivity syndrome manifesting as acute generalised exanthematous pustulosis: A rare case report.
Bragança M; Brandão Abreu D; Moço Coutinho R; Rodrigues Cernadas J; Carneiro-Leão L
Contact Dermatitis; 2024 Apr; 90(4):439-441. PubMed ID: 38234058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
